HIGHLIGHTS
- who: Xiangyu Ma from the School of Pharmacy, Weifang Medical University, Weifang, China, Department of Pharmaceutical Sciences, College of have published the article: The Histone Deacetylase Inhibitor I13 Induces Differentiation of M2, M3 and M5 Subtypes of Acute Myeloid Leukemia Cells and Leukemic Stem-Like Cells, in the Journal: (JOURNAL)
- what: The authors provided the first demonstration that I13 exhibited differentiation-inducing activity in AML cell lines.
- how: The above results indicated that I13 inhibits the proliferation of Kasumi-1 KG-1 MOLM-13 and NB4 cells which is not associated with cell . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.